(Q41672927)

6 October 2017

1 reference

title

Complement and immunity to viruses (English)

1 reference

6 October 2017

Lachmann PJ

1

1 reference

PubMed ID

9416503

6 October 2017

Davies A

series ordinal

2

1 reference

6 October 2017

1 October 1997

1 reference

6 October 2017

Immunological Reviews

1 reference

6 October 2017

159

1 reference

6 October 2017

69-77

1 reference

Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Complement enhancement of HIV infection is mediated by complement receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

Regulation of complement activity by vaccinia virus complement-control protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01007.X

10.1111/J.1600-065X.1997.TB01007.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9416503